Figure 1. Study flow chart. Some patients were excluded for more than one reason. bDMARD, biological disease-modifying antirheumatic drug; I-RMDs, inflammatory rheumatic and musculoskeletal diseases; NI-RMD, non-inflammatory rheumatic and musculoskeletal disease; tsDMARD, targeted synthetic disease-modifying antirheumatic drug.